Detailed answers about INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED founded?
INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED was officially incorporated on 9 June 2025 and is registered under company number 16504197. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED?
INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED do?
INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED operates in the following sectors: 62012 - Business and domestic software development, 63110 - Data processing, hosting and related activities. These SIC codes provide insight into the company's business activities and industry focus.
What is INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED's registered address?
The registered office address of INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED is 18 CROSBY ROAD, DAGENHAM, ENGLAND, RM10 9BH. This is the official address filed with Companies House for legal and statutory correspondence.
Is INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED financially stable?
Financial accounts for INSITU PHARMA HEALTH DATA SOLUTIONS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.